Variant report
Variant | nsv1036539 |
---|---|
Chromosome Location | chr11:107331679-107347234 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:29)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:29 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CBX3 | chr11:107339406-107339761 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr11:107346853-107347156 | K562 | blood: | n/a | chr11:107346997-107347010 chr11:107346997-107347008 chr11:107346999-107347008 chr11:107346997-107347010 chr11:107346999-107347010 |
3 | CEBPB | chr11:107339344-107339654 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr11:107346853-107347169 | A549 | lung: | n/a | chr11:107346997-107347010 chr11:107346997-107347008 chr11:107346999-107347008 chr11:107346997-107347010 chr11:107346999-107347010 |
5 | CEBPB | chr11:107346852-107347105 | HepG2 | liver: | n/a | chr11:107346997-107347010 chr11:107346997-107347008 chr11:107346999-107347008 chr11:107346997-107347010 chr11:107346999-107347010 |
6 | CEBPB | chr11:107346856-107347139 | IMR90 | lung: | n/a | chr11:107346997-107347010 chr11:107346997-107347008 chr11:107346999-107347008 chr11:107346997-107347010 chr11:107346999-107347010 |
7 | CTCF | chr11:107339360-107339510 | HAc | cerebellar: | n/a | n/a |
8 | CTCF | chr11:107339480-107339630 | SK-N-SH_RA | brain: | n/a | n/a |
9 | CTCF | chr11:107339600-107339750 | HMEC | breast: | n/a | n/a |
10 | CTCF | chr11:107339579-107339725 | K562 | blood: | n/a | n/a |
11 | FOS | chr11:107341128-107341298 | MCF10A-Er-Src | breast: | n/a | chr11:107341235-107341245 chr11:107341236-107341245 chr11:107341229-107341241 chr11:107341235-107341245 chr11:107341235-107341245 chr11:107341235-107341245 |
12 | FOXA1 | chr11:107341032-107341355 | HepG2 | liver: | n/a | n/a |
13 | GATA3 | chr11:107338473-107338855 | T-47D | breast: | n/a | chr11:107338652-107338662 |
14 | GATA3 | chr11:107338620-107338928 | T-47D | breast: | n/a | chr11:107338652-107338662 |
15 | MAFF | chr11:107342738-107343018 | HepG2 | liver: | n/a | n/a |
16 | MAFF | chr11:107339495-107339515 | K562 | blood: | n/a | n/a |
17 | MAFF | chr11:107336989-107337130 | HepG2 | liver: | n/a | n/a |
18 | MAFK | chr11:107342719-107342950 | IMR90 | lung: | n/a | n/a |
19 | MAFK | chr11:107342847-107342881 | K562 | blood: | n/a | n/a |
20 | MAFK | chr11:107342742-107342920 | HepG2 | liver: | n/a | n/a |
21 | MAFK | chr11:107342715-107343027 | HepG2 | liver: | n/a | n/a |
22 | MAX | chr11:107339481-107339805 | K562 | blood: | n/a | chr11:107339681-107339691 |
23 | MAX | chr11:107339507-107339801 | NB4 | blood: | n/a | chr11:107339681-107339691 |
24 | MYC | chr11:107339513-107339710 | MCF10A-Er-Src | breast: | n/a | chr11:107339681-107339691 |
25 | POLR2A | chr11:107337291-107337505 | HepG2 | liver: | n/a | n/a |
26 | POLR2A | chr11:107337259-107337484 | HepG2 | liver: | n/a | n/a |
27 | POLR2A | chr11:107339222-107339432 | GM12878 | blood: | n/a | n/a |
28 | RAD21 | chr11:107339557-107339696 | SK-N-SH_RA | brain: | n/a | n/a |
29 | STAT3 | chr11:107339510-107339710 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
CWF19L2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs193009717 | chr11:107336652-107336653 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs529585486 | chr11:107336655-107336656 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550814432 | chr11:107336681-107336682 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs568931247 | chr11:107336706-107336707 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs34292403 | chr11:107336709-107336710 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539413529 | chr11:107336753-107336754 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558116810 | chr11:107336754-107336755 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10400258 | chr11:107336784-107336785 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs185778965 | chr11:107336785-107336786 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186541741 | chr11:107336794-107336795 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574642599 | chr11:107336820-107336821 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113882319 | chr11:107336843-107336844 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542150462 | chr11:107336873-107336874 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557267414 | chr11:107336917-107336918 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527801 | chr11:107336918-107336919 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs10400259 | chr11:107336940-107336941 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs191222761 | chr11:107336980-107336981 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs633543 | chr11:107337017-107337018 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs540314197 | chr11:107337031-107337032 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533311758 | chr11:107337073-107337074 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs199767093 | chr11:107337107-107337108 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562154915 | chr11:107337125-107337126 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372241289 | chr11:107337149-107337150 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550877680 | chr11:107337186-107337187 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs183732516 | chr11:107337220-107337221 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs546907272 | chr11:107337246-107337247 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566705692 | chr11:107337247-107337248 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144948984 | chr11:107337261-107337262 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs551529186 | chr11:107337283-107337284 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536170554 | chr11:107337320-107337321 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566846963 | chr11:107337332-107337333 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535623265 | chr11:107337342-107337343 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572400269 | chr11:107337364-107337365 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375138936 | chr11:107344201-107344202 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs568775843 | chr11:107344227-107344228 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs151038844 | chr11:107344242-107344243 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs140972020 | chr11:107344247-107344248 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572650588 | chr11:107344354-107344355 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35220178 | chr11:107344395-107344396 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536184823 | chr11:107344458-107344459 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs733811 | chr11:107344568-107344569 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs185346253 | chr11:107344592-107344593 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573867009 | chr11:107344601-107344602 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544592335 | chr11:107344607-107344608 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs563230670 | chr11:107344642-107344643 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs569461362 | chr11:107344667-107344668 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545430363 | chr11:107344715-107344716 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs624584 | chr11:107344724-107344725 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs527797115 | chr11:107344729-107344730 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369684066 | chr11:107344758-107344759 | Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Obesity | 19966786 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:107336600-107337400 | Active TSS | HepG2 | liver |
2 | chr11:107344200-107345000 | Enhancers | Fetal Kidney | kidney |
3 | chr11:107344200-107345200 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr11:107344600-107345800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |